Lipid-lowering effect of tenofovir in HIV-infected patients

被引：27
|
作者：
Fabbiani, Massimiliano [1 ]
Bracciale, Laura [1 ]
Doino, Maria [1 ]
Sidella, Letizia [1 ]
Farina, Salvatore [1 ]
Di Cristo, Valentina [1 ]
Cauda, Roberto [1 ]
De Luca, Andrea [1 ,2 ]
Di Giambenedetto, Simona [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, I-00168 Rome, Italy
[2] Siena Univ Hosp, Infect Dis Unit 2, Siena, Italy
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2011年 / 66卷 / 03期
关键词：
cholesterol; simplification; antiretroviral therapy; cardiovascular risk;
D O I：
10.1093/jac/dkq464
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：682 / 683
页数：2
相关论文
共 50 条
  • [41] Lipid accumulation product index in HIV-infected patients: a marker of cardiovascular risk
    Moreira Guimaraes, Milena Maria
    Greco, Dirceu Bartolomeu
    Moreira, Allyson Nogueira
    Guimaraes, Nathalia Sernizon
    Vilas Freire, Claudia Maria
    Rohlfs, Bruna Guimaraes
    de Campos Machado, Lucas Jose
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2018, 22 (03) : 171 - 176
  • [42] Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate
    Pradat, P.
    Le Pogam, M. -A.
    Okon, J. -B.
    Trolliet, P.
    Miailhes, P.
    Brochier, C.
    Maynard, M.
    Bailly, F.
    Zoulim, F.
    Cotte, L.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (09) : 650 - 657
  • [43] Tenofovir alafenamide plus dolutegravir as a switch strategy in HIV-infected patients: a pilot randomized controlled trial
    Golbarg Alavian
    Ladan Abbasian
    Hossein Khalili
    Seyed Ahmad Seyed Alinaghi
    Malihe Hasannezhad
    Masoumeh Farrokh Ashtiani
    Seyed Ali Dehghan Manshadi
    DARU Journal of Pharmaceutical Sciences, 2023, 31 : 145 - 153
  • [44] Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization
    Kadoglou, Nikolaos P. E.
    Sailer, Nikolaos
    Moumtzouoglou, Anestis
    Kapelouzou, Alkistis
    Gerasimidis, Thomas
    Liapis, Christos D.
    JOURNAL OF VASCULAR SURGERY, 2010, 51 (01) : 114 - 121
  • [45] Arterial hypertension and cardiovascular risk in HIV-infected patients
    Calo, Lorenzo A.
    Caielli, Paola
    Maiolino, Giuseppe
    Rossi, Gianpaolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 (08) : 553 - 558
  • [46] Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients
    Gianotti, Nicola
    Poli, Andrea
    Nozza, Silvia
    Galli, Laura
    Galizzi, Nadia
    Ripa, Marco
    Merli, Marco
    Carbone, Alessia
    Spagnuolo, Vincenzo
    Lazzarin, Adriano
    Castagna, Antonella
    BMC INFECTIOUS DISEASES, 2017, 17
  • [47] Lipid profile during pregnancy in HIV-infected women
    Floridia, M.
    Tamburrini, E.
    Ravizza, M.
    Tibaldi, C.
    Probizer, M. F. Ravagni
    Anzidei, G.
    Sansone, M.
    Mori, F.
    Rubino, E.
    Meli, M.
    Dalzero, S.
    Guaraldi, G.
    HIV CLINICAL TRIALS, 2006, 7 (04): : 184 - 193
  • [48] Tenofovir alafenamide plus dolutegravir as a switch strategy in HIV-infected patients: a pilot randomized controlled trial
    Alavian, Golbarg
    Abbasian, Ladan
    Khalili, Hossein
    Alinaghi, Seyed Ahmad Seyed
    Hasannezhad, Malihe
    Ashtiani, Masoumeh Farrokh
    Manshadi, Seyed Ali Dehghan
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 31 (02) : 145 - 153
  • [49] ANTIRETROVIRAL THERAPY AND ARTERIAL ELASTICITY IN HIV-INFECTED PATIENTS
    Kundro, Mariana A.
    Viloria, Guillermo A.
    Toibaro, Javier J.
    Losso, Marcelo H.
    MEDICINA-BUENOS AIRES, 2017, 77 (05) : 365 - 369
  • [50] Nutritional Status and Lipid Profile in HIV-Infected Adults
    Stambullian, M.
    Feliu, M. S.
    Cassetti, L. I.
    Slobodianik, N. H.
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2015, 15 (04) : 302 - 307
12345